Image cytometry and chemoprevention in cervical cancer
- 1 January 1995
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 59 (S23) , 43-54
Abstract
Of the approximately 60 million Pap smears performed in the United States in 1995, about 8% or 5 million will show cytology that is “not negative” (ASCUS, AGCUS, LSIL, HSIL, etc.). Possibly 15% or about 0.7 million of these cases will have positive follow‐up by repeated Pap smears, colposcopy or biopsy. More than 4 million will be false‐positive smears based on the reference standard of biopsy or repeated smears. If no treatment or medical intervention was offered to the 0.7 million cytologically and histologically positive cases, perhaps 20,000 (3%) would develop into invasive cancer. Of the original 5 million cytologically “not negative” cases, fewer than 0.5% have the potential to develop into invasive cancer. While considerable attention has been paid to false‐negatives in Pap screening, the above considerations indicate that the cytological and histological criteria for assessing the malignant potential of “not negative” samples might benefit from some refinement. Until such refinement occurs, any chemoprevention studies in cervix face a formidable signal‐to‐noise problem—worse than 1:30. This paper presents data from quantitative image cytometry of cervical smears for assessing the malignant potential of various “not negative” cases. We have approached this in two ways—by analyzing dysplastic cell nuclei and by analyzing the nuclei of cytologically normal cells growing in the vicinity of the neoplastic lesion. In both cases, nuclear features describing the distribution of the DNA in the cell nuclei (especially texture features) are the discriminating factors. Future research into the objective assessment of malignant potential of “not negative” cases is outlined.Keywords
This publication has 9 references indexed in Scilit:
- Interim Guidelines for Management of Abnormal Cervical CytologyJAMA, 1994
- Low‐grade squamous intraepithelial lesions: Cytologic predictors of biopsy ConfirmationDiagnostic Cytopathology, 1994
- Reactive change and atypical squamous cells of undetermined significance in papanicolaou smears: A cytohistologic correlationDiagnostic Cytopathology, 1993
- Preventive Pap-smears: balancing costs, risks and benefitsBritish Journal of Cancer, 1992
- Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcomeThe Lancet, 1992
- Pruritic urticarial papules and plaques of pregnancyJournal of Obstetrics and Gynaecology, 1992
- The Papanicolaou Test for Cervical Cancer DetectionJAMA, 1989
- Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85BMJ, 1988
- Papanicolaou Smear Screening and Cervical CancerJAMA, 1984